These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26796541)

  • 1. Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children.
    Vet NJ; Brussee JM; de Hoog M; Mooij MG; Verlaat CW; Jerchel IS; van Schaik RH; Koch BC; Tibboel D; Knibbe CA; de Wildt SN;
    Am J Respir Crit Care Med; 2016 Jul; 194(1):58-66. PubMed ID: 26796541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of critical illness and inflammation on midazolam therapy in children.
    Vet NJ; de Hoog M; Tibboel D; de Wildt SN
    Pediatr Crit Care Med; 2012 Jan; 13(1):e48-50. PubMed ID: 21057365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.
    Brussee JM; Vet NJ; Krekels EHJ; Valkenburg AJ; Jacqz-Aigrain E; van Gerven JMA; Swart EL; van den Anker JN; Tibboel D; de Hoog M; de Wildt SN; Knibbe CAJ
    Br J Clin Pharmacol; 2018 Feb; 84(2):358-368. PubMed ID: 29072785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach.
    Brussee JM; Yu H; Krekels EHJ; Palić S; Brill MJE; Barrett JS; Rostami-Hodjegan A; de Wildt SN; Knibbe CAJ
    Pharm Res; 2018 Jul; 35(9):182. PubMed ID: 30062590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical illness is a major determinant of midazolam clearance in children aged 1 month to 17 years.
    Ince I; de Wildt SN; Peeters MY; Murry DJ; Tibboel D; Danhof M; Knibbe CA
    Ther Drug Monit; 2012 Aug; 34(4):381-9. PubMed ID: 22660604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel maturation function for clearance of the cytochrome P450 3A substrate midazolam from preterm neonates to adults.
    Ince I; de Wildt SN; Wang C; Peeters MY; Burggraaf J; Jacqz-Aigrain E; van den Anker JN; Tibboel D; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2013 Jul; 52(7):555-65. PubMed ID: 23512668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure.
    Carcillo JA; Doughty L; Kofos D; Frye RF; Kaplan SS; Sasser H; Burckart GJ
    Intensive Care Med; 2003 Jun; 29(6):980-984. PubMed ID: 12698250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children.
    Brussee JM; Krekels EHJ; Calvier EAM; Palić S; Rostami-Hodjegan A; Danhof M; Barrett JS; de Wildt SN; Knibbe CAJ
    AAPS J; 2019 Jun; 21(5):81. PubMed ID: 31250333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of midazolam clearance in critically ill children with severe bronchiolitis: A population pharmacokinetic analysis.
    Kos MK; Miksić M; Jovanović M; Roškar R; Grosek Š; Grabnar I
    Eur J Pharm Sci; 2020 Jan; 141():105095. PubMed ID: 31626965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study.
    van Groen BD; Krekels EHJ; Mooij MG; van Duijn E; Vaes WHJ; Windhorst AD; van Rosmalen J; Hartman SJF; Hendrikse NH; Koch BCP; Allegaert K; Tibboel D; Knibbe CAJ; de Wildt SN
    Clin Pharmacol Ther; 2021 Jan; 109(1):140-149. PubMed ID: 32403162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of midazolam in critically ill pediatric patients.
    Nahara MC; McMorrow J; Jones PR; Anglin D; Rosenberg R
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):219-21. PubMed ID: 11420893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN; de Hoog M; Vinks AA; van der Giesen E; van den Anker JN
    Crit Care Med; 2003 Jul; 31(7):1952-8. PubMed ID: 12847388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of different sedation regimens on sedation and inflammatory response in critically ill children with multiple trauma].
    Tong W; Song C; Jin D; Sun J; Wang Y; Xu D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):542-546. PubMed ID: 28625245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
    Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
    J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of midazolam in neonates.
    Burtin P; Jacqz-Aigrain E; Girard P; Lenclen R; Magny JF; Betremieux P; Tehiry C; Desplanques L; Mussat P
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):615-25. PubMed ID: 7995003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state plasma concentrations of midazolam in critically ill infants and children.
    Hughes J; Gill AM; Mulhearn H; Powell E; Choonara I
    Ann Pharmacother; 1996 Jan; 30(1):27-30. PubMed ID: 8773161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rs776746 variant of CYP3A5 is associated with intravenous midazolam plasma levels and higher clearance in critically ill Mexican paediatric patients.
    Flores-Pérez C; Castillejos-López MJ; Chávez-Pacheco JL; Dávila-Borja VM; Flores-Pérez J; Zárate-Castañón P; Acosta-Bastidas M; Cruz-Escobar J; Torres-Espíndola LM
    J Clin Pharm Ther; 2021 Jun; 46(3):633-639. PubMed ID: 33638195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study.
    Zuppa AF; Conrado DJ; Zane NR; Curley MAQ; Bradfield J; Hakonarson H; Gastonguay MS; Moorthy G; Prodell J; Gastonguay MR
    Crit Care Med; 2019 Apr; 47(4):e301-e309. PubMed ID: 30672747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19.
    Smeets TJL; Valkenburg AJ; van der Jagt M; Koch BCP; Endeman H; Gommers DAMPJ; Sassen SDT; Hunfeld NGM
    Clin Pharmacokinet; 2022 Jul; 61(7):973-983. PubMed ID: 35397768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.